AzTrials
AzTrials

NeuromodulationNCT04936659

Effect of Palpatory Neuromodulation of the Trigeminal Nerve for Tenderness in the Posterior Neck Musculature

A study testing neuromodulation in people with Neuromodulation and Neck Pain, run by University of North Texas Health Science Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess the extent to which a non-invasive, palpatory neuromodulatory protocol on the trigeminal nerve endings on the face can affect tenderness felt on the posterior neck musculature, using the Isotouch pressure sensor system. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Neuromodulation, Neck Pain
What is being tested?
neuromodulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
78 participants
Where
1 siteUnited States
Study dates
13 Oct 2017to 1 May 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • . Aged 18-65 2. Has posterior neck muscle discomfort 3. Has none of the following within the past 12 months:
  • traumatic brain injury
  • concussion
  • whiplash
  • dental work (cavity filling, root canal, tooth extraction, tooth implantation)
  • facial trauma
Show all 16Show fewer
  • facial reconstruction surgery
  • diagnosis of migraine headaches with daily or weekly medication use
  • diagnosis of cluster type headaches with daily or weekly medication use 4. No neurological diagnoses, such as:
  • trigeminal neuralgia
  • facial numbness
  • paralysis of the face 5. No cervical spine issues such as:
  • Bulging disc
  • Vertebral fusion surgery
  • Vertebral disc removal surgery 6. No skin disorder of the face, neck or scalp such as:
  • Shingles/Herpes Zoster 7. Subject is able to lay supine for 15 minutes 8. Not pregnant

Who cannot join

  • 1. Below the age of 18 or over the age of 65 2. Any of the following within the past 12 months:
  • traumatic brain injury
  • concussion
  • whiplash
  • dental work (cavity filling, root canal, tooth extraction, tooth implantation)
  • facial trauma
Show all 16Show fewer
  • facial reconstruction surgery.
  • Diagnosis of migraine headaches with daily or weekly medication use
  • Diagnosis of cluster headaches with daily or weekly medication use 3. Any of the following neurologic diagnoses:
  • trigeminal neuralgia
  • facial numbness
  • paralysis of the face
  • Cervical spine issues (bulging disc, vertebral fusion, or vertebral disc removal)
  • Skin disorders of the face, neck, or scalp such as Shingles or Herpes Zoster
  • Pregnancy
  • Unable to lay on back for 15 minutes

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of North Texas Health Science Center

    Fort Worth, Texas, 76107

Other trials in United States

About this study

The purpose of this study is to assess the extent to which a non-invasive, palpatory neuromodulatory protocol on the trigeminal nerve endings on the face can affect tenderness felt on the posterior neck musculature, using the Isotouch pressure sensor system.

Specific Aim 1: Subjects will see a decrease in tenderness in the posterior neck musculature.

Specific Aim 2: Subjects will show a decrease in tenderness on the trigeminal tender points found on the face.

Read the detailed description

Study Instrumentation: The Isotouch sensor device and software is a passive sensor device that allows for real-time, constant visualization of pressure information. The system electronics are remote (on the packet usually worn on the wrist) and the current supports a Bluetooth data stream. The sensor has input power on the wrist and minimal microcurrent output. The pressure range for the device ranges from 0-100 pounds per square inch (PSI), although this study will only be using pressure of 0.5 to three pounds of pressure. The sensors are made of both cloth and Polyimide material. This software will be directly used in the neuromodulatory intervention as described below. The sensors will be used both for the palpatory evaluation of trigeminal tender points on the face as well as the neuromodulation portion of the protocol.

Subjects interested in the study will email the NeckPainResearch@unthsc.edu account to express their interest in participating. The co-investigators will email the subject an initial survey to answer questions about the inclusion and exclusion criteria. This survey will primarily consist of questions related to the potential participant's medical history, to best determine if they qualify for the study. If subjects qualify, they will be contacted via telephone (by the principal or a co-investigator) to schedule a time to participate in the study visit. Once a visit is scheduled, the participant will meet the investigators in a private setting either at the UNTHSC campus or other community based designated area. After the consenting process is completed, the inclusion and exclusion criteria will be re-reviewed. If the subject qualifies, they will be consented and fill out a brief questionnaire. Subjects will be verbally asked for demographic information including their age, weight, height, gender, and have their neck circumference measured by the principal investigator or a co-investigator.

After consenting, the subject will be taken to the operator (the principal or co-investigator) who will be in clinical patient room with the IsoTouch software (see diagram). The subject will lie supine on the exam table.

The operator will be wearing two IsoTouch finger sensors; one on each index finger. Non-latex coverings will be used over the IsoTouch software pressure sensors to protect the instrumentation from the natural oils of human skin, as well as the participant. The operator will palpate 1 inch posteromedial from the posterior aspect of the mastoid process (posterior neck) on each side with 3 pounds of pressure to determine if any tenderness is present, and the subject will verbally give a pain rating between 0-10. This will be referred to as the left and right cervical sites of tenderness (CSOT).

Next, using the IsoTouch finger sensor, the trigeminal nerve endings will be palpated for tenderness with 2 lbs of pressure and subjects will verbally give a pain rating on a scale of 0-10 at the following sites: V1, and V2 branches of the trigeminal nerve on the face which will be referred to as trigeminal tender points (TTPs, see below diagram). The three most tender TTPs will be documented.

Two lbs of pressure will be used on the facial sites as the anatomy is significantly different. The facial structures in general are much more superficial than the layers of musculature in the posterior neck. Therefore, the pressure will be less on the face than it is on the posterior neck musculature.

The operator will keep one monitoring sensor with minimal pressure (less than 0.5 lbs of pressure) at the CSOT while the other sensor/sensing hand applies steady pressure to each of the TTPs. The CSOT remains the same throughout the protocol and does not change sides, as it will be reevaluated when the protocol is completed.

The three most tender TTPs will be palpated with steady pressure (two lbs of pressure) for 30 seconds, as this step is the neuromodulation intervention. In the event that there are two tender points rated the same (and not zero), the investigators will repeat assessment of each trigeminal area again to be rated by the subject. If it happens that the same values are again recorded, the investigators will include both tender points in our protocol, potentially including four TTPs in the intervention. Any anomalies will be noted in the data collection. The steady pressure is continuously recorded via the pressure sensing IsoTouch pads and monitored in real time by the operator to keep it consistent with each intervention. After the TTP's have the intervention, their face will not be touched again.

After all three of the TTPs assessed to have tenderness have received the intervention, the CSOT will be rechecked with the same initial pressure (3lbs) to evaluate pain changes.

For Example, The CSOT on the right was assessed to have an 8/10 tenderness to palpation. V1R, V2R, V2L were found to have the most tenderness. In sequential order, V1R, V2R, V2L will have the neuromodulatory pulsations applied to them, and when complete, the right sided CSOT will be rechecked.

Due to the force signal drift of the ISOTOUCH, and the real-time nature of the software, the pressure/force will be monitored and adjusted accordingly to maintain the appropriate pressure/force throughout the intervention.

This neuromodulatory protocol is finished when the TTPs that were assessed to have the most tenderness each had the 30 second intervention.

The protocol will be ended immediately if any subject asks to stop, or if any significant pain or side effects develop.

Being tested
neuromodulation
Keywords
trigeminal nerve
Medical subject headings
Neck Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • neuromodulationOther

    Palpatory neuromodulation of the V1 and V2 branches of the trigeminal nerve where they exit onto the face.

Study groups in NCT04936659
Study groupRoleWhat they receive
Treatment groupExperimentalNot described
Receives: Other: neuromodulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cervical muscle tenderness

    Palpatory assessment of muscle tenderness measured on a visual analog scale of 0-10

    Measured: Change from pre to immediately post intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2021
  2. Study start13 Oct 2017
  3. Primary completion30 May 2019
  4. Study completion1 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
78 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04936659
Sponsor's protocol ID
1444471
Status last verified
Jun 2021
First submitted
12 Mar 2021
Last updated
25 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing neuromodulation in people with Neuromodulation and Neck Pain, run by University of North Texas Health Science Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cervical muscle tenderness (time frame: Change from pre to immediately post intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in